annual SGA:
$236.67M-$13.08M(-5.24%)Summary
- As of today (May 21, 2025), RPRX annual SGA is $236.67 million, with the most recent change of -$13.08 million (-5.24%) on December 31, 2024.
- During the last 3 years, RPRX annual SGA has risen by +$53.84 million (+29.45%).
- RPRX annual SGA is now -5.24% below its all-time high of $249.75 million, reached on December 31, 2023.
Performance
RPRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$110.70M+$43.11M(+63.79%)Summary
- As of today (May 21, 2025), RPRX quarterly SGA is $110.70 million, with the most recent change of +$43.11 million (+63.79%) on March 31, 2025.
- Over the past year, RPRX quarterly SGA has increased by +$53.05 million (+92.02%).
- RPRX quarterly SGA is now at all-time high.
Performance
RPRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$10.47B+$53.22M(+0.51%)Summary
- As of today (May 21, 2025), RPRX TTM SGA is $10.47 billion, with the most recent change of +$53.22 million (+0.51%) on March 31, 2025.
- Over the past year, RPRX TTM SGA has increased by +$10.25 billion (+4622.15%).
- RPRX TTM SGA is now at all-time high.
Performance
RPRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RPRX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.2% | +92.0% | +4622.1% |
| 3 y3 years | +29.4% | +114.8% | +5375.3% |
| 5 y5 years | +128.8% | +190.8% | +8842.1% |
RPRX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.2% | +29.4% | at high | +132.4% | at high | +22.2% |
| 5 y | 5-year | -5.2% | +128.8% | at high | +190.8% | at high | +94.3% |
| alltime | all time | -5.2% | +282.3% | at high | +380.1% | at high | +270.6% |
RPRX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $110.70M(+63.8%) | $289.72M(+22.4%) |
| Dec 2024 | $236.67M(-5.2%) | $67.59M(+19.2%) | $236.67M(+3.7%) |
| Sep 2024 | - | $56.72M(+3.7%) | $228.26M(-0.2%) |
| Jun 2024 | - | $54.71M(-5.1%) | $228.78M(+3.2%) |
| Mar 2024 | - | $57.65M(-2.6%) | $221.71M(-11.2%) |
| Dec 2023 | $249.75M(+9.9%) | $59.19M(+3.4%) | $249.75M(-5.3%) |
| Sep 2023 | - | $57.23M(+20.2%) | $263.79M(+2.5%) |
| Jun 2023 | - | $47.63M(-44.4%) | $257.25M(-1.6%) |
| Mar 2023 | - | $85.69M(+17.0%) | $261.46M(+15.0%) |
| Dec 2022 | $227.30M(+24.3%) | $73.23M(+44.5%) | $227.30M(+13.5%) |
| Sep 2022 | - | $50.69M(-2.2%) | $200.24M(+1.1%) |
| Jun 2022 | - | $51.84M(+0.6%) | $198.13M(+3.6%) |
| Mar 2022 | - | $51.54M(+11.7%) | $191.21M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $182.83M(+0.6%) | $46.16M(-5.0%) | $182.83M(-2.1%) |
| Sep 2021 | - | $48.59M(+8.2%) | $186.78M(-1.1%) |
| Jun 2021 | - | $44.92M(+4.1%) | $188.93M(+1.1%) |
| Mar 2021 | - | $43.16M(-13.9%) | $186.81M(+2.8%) |
| Dec 2020 | $181.72M(+75.7%) | $50.12M(-1.2%) | $181.72M(+17.5%) |
| Sep 2020 | - | $50.73M(+18.5%) | $154.66M(+19.4%) |
| Jun 2020 | - | $42.80M(+12.4%) | $129.53M(+10.6%) |
| Mar 2020 | - | $38.06M(+65.1%) | $117.08M(+13.2%) |
| Dec 2019 | $103.44M(+67.1%) | $23.06M(-9.9%) | $103.44M(+28.7%) |
| Sep 2019 | - | $25.60M(-15.6%) | $80.38M(+46.7%) |
| Jun 2019 | - | $30.35M(+24.2%) | $54.77M(+124.2%) |
| Mar 2019 | - | $24.43M | $24.43M |
| Dec 2018 | $61.91M(-41.8%) | - | - |
| Dec 2017 | $106.44M | - | - |
FAQ
- What is Royalty Pharma annual SGA?
- What is the all time high annual SGA for Royalty Pharma?
- What is Royalty Pharma annual SGA year-on-year change?
- What is Royalty Pharma quarterly SGA?
- What is the all time high quarterly SGA for Royalty Pharma?
- What is Royalty Pharma quarterly SGA year-on-year change?
- What is Royalty Pharma TTM SGA?
- What is the all time high TTM SGA for Royalty Pharma?
- What is Royalty Pharma TTM SGA year-on-year change?
What is Royalty Pharma annual SGA?
The current annual SGA of RPRX is $236.67M
What is the all time high annual SGA for Royalty Pharma?
Royalty Pharma all-time high annual SGA is $249.75M
What is Royalty Pharma annual SGA year-on-year change?
Over the past year, RPRX annual SGA has changed by -$13.08M (-5.24%)
What is Royalty Pharma quarterly SGA?
The current quarterly SGA of RPRX is $110.70M
What is the all time high quarterly SGA for Royalty Pharma?
Royalty Pharma all-time high quarterly SGA is $110.70M
What is Royalty Pharma quarterly SGA year-on-year change?
Over the past year, RPRX quarterly SGA has changed by +$53.05M (+92.02%)
What is Royalty Pharma TTM SGA?
The current TTM SGA of RPRX is $10.47B
What is the all time high TTM SGA for Royalty Pharma?
Royalty Pharma all-time high TTM SGA is $10.47B
What is Royalty Pharma TTM SGA year-on-year change?
Over the past year, RPRX TTM SGA has changed by +$10.25B (+4622.15%)